Advertisement

Absorption of digoxin from the distal parts of the intestine in man

  • H. Ochs
  • G. Bodem
  • P. K. Schäfer
  • G. Kodrat
  • H. J. Dengler
Article

Summary

In 12 patients undergoing coloscopy, 0.5 mg digoxin in aqueous alcoholic solution was injected into the transverse colon. The late maximum of the blood level curve at about 2 hours after the administration suggested delayed absorption of the glycoside. However, the 24 hour urinary excretion of 17±3.4% in 8 patients with normal colonic mucosa demonstrated extensive absorption in the distal part of the bowel. The results have been contrasted with the findings in 4 patients with ulcerative colitis who excreted only 1.66±0.6% of the given dose in 24 hours.

Key words

Bioavailability digoxin colon colitis ulcerosa 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Beermann, B., Hellström, K., Rosén, A.: The absorption of orally administered 12 α-3H-digoxin in man. Clin. Sci.43, 507–518 (1972)Google Scholar
  2. 2.
    Dengler, H.J., Bodem, G., Wirth, K.: Pharmakokinetische Untersuchungen mit3H-Digoxin und3H-Lanatosid beim Menschen. Arzneimittel-Forsch.23, 64–74 (1973)Google Scholar
  3. 3.
    Greenberger, N.J., MacDermott, R.P., Martin, J.F., Dutta, S.: Intestinal absorption of six tritium-labelled digitalis glycosides in rats and guinea pigs. J. Pharmacol. exp. Ther.167, 265 (1969)Google Scholar
  4. 4.
    Hall, W.H., Doherty, J.E.: Tritiated digoxin. XVI. Gastric absorption.Dig. Dis. 16, 903–908 (1971)Google Scholar
  5. 5.
    Hall, W.H., Doherty, J.E.: Tritiated digoxin. XXII. Absorption and excretion in malabsorption syndromes. Amer. J. Med.56, 437–442 (1974)Google Scholar
  6. 6.
    Harris, J., Shields, R.: Absorption and secretion of water and electrolytes by the intact human colon in diffuse untreated proctocolitis. Gut11, 27–33 (1970)Google Scholar
  7. 7.
    Heizer, W.D., Smith, T.W., Goldfinger, S.E.: Absorption of digoxin in patients with malabsorption syndromes. New Engl. J. Med.285, 257–259 (1971)Google Scholar
  8. 8.
    Ochs, H., Bodem, G., Savic, M., Kodrat, G., Baur, M.P.: Biologische Verfügbarkeit von Digoxin bei Patienten mit und ohne Magenresektion nach Billroth II. Dtsch. med. Wschr. (in press)Google Scholar
  9. 9.
    Smith, T.W., Haber, E.: Current techniques for serum or plasma digitalis assay and their potential clinical application. Amer. J. med. Sci.259, 301 (1970)Google Scholar
  10. 10.
    Wagner, J.G.: Appraisal of digoxin bioavailability and pharmacokinetics in relation to cardiac therapy. Amer. Heart J.88, 133–138 (1974)Google Scholar
  11. 11.
    White, R.J., Chamberlain, D.A., Howard, M., Smith, T.W.: Plasma concentrations of digoxin after oral administration in the fasting and postprandial state. Brit. med. J.1971 I, 380–381Google Scholar

Copyright information

© Springer-Verlag 1975

Authors and Affiliations

  • H. Ochs
    • 1
  • G. Bodem
    • 1
  • P. K. Schäfer
    • 1
  • G. Kodrat
    • 1
  • H. J. Dengler
    • 1
  1. 1.Medizinische Universitäts-Klinik Bonn-VenusbergFederal Republic of Germany

Personalised recommendations